Navigating New Regulations in Biobanking for Clinical Studies and Research Projects

Stability storage and testing

Join us to hear Prof. Jonathan Douxfils, CEO and Co-Founder of QUALIblood, as he explains the latest regulations in biobanking and their impact on clinical studies, what changes researchers may need to implement in their projects, and the potential challenges in complying with these new regulations.

Key takeaways include:

  • Importance of biobanking in advancing medical research and personalized treatments.
  • Need for regulations to ensure ethical and legal practices in biobanking.
  • How the latest regulations are impacting biobanking for clinical studies and research projects.